本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

因塞特医疗

68.77
+1.532.28%
盘后68.770.00000.00%16:59 EDT
成交量:171.98万
成交额:1.18亿
市值:133.12亿
市盈率:708.79
高:68.98
开:67.78
低:67.62
收:67.24
数据加载中...
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/30

重要事件披露

Form 8-K - Current report
2024/07/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/24

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/04

重要事件披露

Form 8-K - Current report
2024/06/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/03/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/16

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]